Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-16-006767
Filing Date
2016-07-26
Accepted
2016-07-26 07:01:13
Documents
4
Period of Report
2016-07-26

Document Format Files

Seq Description Document Type Size
1 6-K rdhl-20160726x6k.htm 6-K 15031
2 EX-1 rdhl-20160726ex1b5767438.htm EX-1 364043
3 EX-2 rdhl-20160726xex2.htm EX-2 598615
4 GRAPHIC rdhl20160726ex1b5767438001.jpg GRAPHIC 14006
  Complete submission text file 0001558370-16-006767.txt   992692
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 161783090
SIC: 2834 Pharmaceutical Preparations